MHO vs RARE · P/E 6.2, rev $1.98B vs rev $350.0M
M/I Homes Inc (MHO) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
M/I Homes Inc (MHO) is a residential construction company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported MHO revenue for 2026-06-30 was $1.98B. Net income was $146.9M. MHO currently screens at market cap $3.12B and trailing P/E 6.2.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
MHO currently screens at market cap $3.12B and trailing P/E 6.2. RARE currently screens at market cap $2.79B.
Not investment advice. Open the MHO and RARE stock pages for the full models.
Not investment advice.